Skip to main content
US EQUITIES OPEN CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
MC

MCKStock

New York Stock Exchange · Healthcare · US

$1,081.88 last close 2026-11-18
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment MCK's does — no target price to set, unlike a price alert.

Near limit Ratio screen, 6 of 7 decided standards passing. Dow Jones Islamic is within 3 points of its line. Even if it crossed, the majority verdict would stay Compliant. What would change it

Ethical flags Border & immigration enforcementPrisons & detention Documented concerns, not part of the Sharia verdict.

CONTROVERSY

Border & immigration enforcement MCKESSON CORPORATION received $18,592,000 in prime contracts from U.S. Immigration and Customs Enforcement between 2024-09-09 and 2026-09-09. Source: USAspending.gov (US Treasury) (link) · as of 2026-09-09.

Prisons & detention MCKESSON CORPORATION received $397,570,161 in prime contracts from Federal Prison System / Bureau of Prisons between 2024-09-09 and 2026-09-09. Source: USAspending.gov (US Treasury) (link) · as of 2026-09-09.

Each line names its source: a public record or a named body's listing, not a Sharia ruling and not our assessment of this company. It sits beside the verdict above and changes nothing about it.

Sharia status
COMPLIANT
Per our in-house ratio engine
6 of 7 pass our own screen — the standards disagree
🕌 Held by HLAL · MNZL Purification 0.04% *HTR non-permissible income 0.04%
🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
🟢 STRONG BUY SETUP
Strong confluence across multiple layers — outperforming the market by 11.3%, RSI in healthy zone, Wall Street...
Scores: 4 bullish / 1 bearish
34
of 100
Setup confidence — system conviction, not win probabilityF

Trade plan

Posted with a stop, a target and the level that invalidates it. It resolves into the public record either way.

MOM · SCALP
Entry
$892.72
Stop
$883.79
Target
$910.58
Risk : Reward 2.0R

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure2 of 5 timeframes bullish · 30.4% aligned
VWAPPrice below VWAP ($1096.19)
VolumeRelative volume 2.5× the 20-day average
Momentum10-day rate of change +0.7%
Overall readSTRONG BUY SETUP

MCK is currently considered halal (Sharia-compliant), per our in-house ratio engine. See the full ratio breakdown and business-activity screen below for the reasoning.

This sits among 434 compliant Healthcare stocks we track. See compliant Healthcare stocks →

Market & analysts
Wall Street consensus
BUY
24 analysts · worsening
Institutional own.
93.6%
of shares
Momentum (10d)
+0.7%
rate of change
SMC grade
F · 34
30.4% aligned
🕌 HLAL, MNZL
Held by real halal ETF(s)
0.04% *
Purification ratio (secondary provider, uncertain)
0.04%
Non-permissible income — HTR, from filings (2026-03-31)
F · 34
SMC grade — 30.4% timeframe alignment
+0.7%
Rate of change (10d)
BUY ↘
Wall Street consensus (24) — worsening
93.6%
Institutional ownership

How the status reached this point

Compliant · status tracked since Nov 17, 2026

No change to MCK’s published status has been recorded since our daily status check began on Nov 17, 2026. What it read before then is not on record here.

Read once a day from our own screen, last on Nov 17, 2026. The per-methodology record is under “What changed, and when” in the in-house research.

Free email, sent when our compliance re-scan finds a change.

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2026-09-30. These ratios come from the issuer's own published statements rather than structured SEC data.

AAOIFI divides by the market cap: $126.0B as of 2026-11-18.

Business activity: cleared (no excluded categories detected)

AAOIFI Pass 3 of 3 ratios pass
RatioValueThresholdResult
Interest-bearing debt 9.49% 30.00% Pass(20.5pp buffer)
Interest-bearing investments 5.25% 30.00% Pass(24.7pp buffer)
Non-permissible income 0.04% 5.00% Pass(5.0pp buffer)
Usmani Pass 4 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 12.95% 33.00% Pass(20.1pp buffer)
Interest-bearing investments 7.17% 33.00% Pass(25.8pp buffer)
Non-liquid assets 59.46% at least 20.00% Pass(39.5pp above the floor)
Non-permissible income 0.04% 5.00% Pass(5.0pp buffer)
MSCI Fail 3 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 12.95% 33.33% Pass(20.4pp buffer)
Cash + interest-bearing securities 7.17% 33.33% Pass(26.2pp buffer)
Accounts receivable 40.54% 33.33% Fail(7.2pp over)
Non-permissible income 0.04% 5.00% Pass(5.0pp buffer)
FTSE Pass 4 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 10.83% 33.33% Pass(22.5pp buffer)
Cash + interest-bearing securities 7.17% 33.33% Pass(26.2pp buffer)
Accounts receivable 40.54% 50.00% Pass(9.5pp buffer)
Non-permissible income 0.04% 5.00% Pass(5.0pp buffer)
Dow Jones Islamic Market Fail 3 of 4 ratios pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 13.27% 33.00% Pass(19.7pp buffer)
Cash + interest-bearing securities 7.35% 33.00% Pass(25.7pp buffer)
Accounts receivable 34.20% 33.00% Fail(1.2pp over)
Non-permissible income 0.04% 5.00% Pass(5.0pp buffer)
S&P Shariah Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 14.90% 33.00% Pass(18.1pp buffer)
Cash + interest-bearing securities 8.25% 49.00% Pass(40.8pp buffer)
Accounts receivable 38.39% 49.00% Pass(10.6pp buffer)
Non-permissible income 0.04% 5.00% Pass(5.0pp buffer)
MSCI M-Series Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 14.90% 33.33% Pass(18.4pp buffer)
Cash + interest-bearing securities 8.25% 33.33% Pass(25.1pp buffer)
Accounts receivable 46.64% 49.00% Pass(2.4pp buffer)
Non-permissible income 0.04% 5.00% Pass(5.0pp buffer)

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

How close is it to flipping?

Every current reading against its own line, closest first. A verdict is only as durable as that distance.

MSCI Islamic M-Series (% of 36-mo avg market cap)receivables ratio 2.4pts
AAOIFI Standard 21 (% of market cap)non permissible income ratio 5.0pts
Usmani (% of total assets)non permissible income ratio 5.0pts
MSCI Islamic Index (% of total assets)receivables ratio 7.2pts
Dow Jones Islamic Market (% of 24-mo avg market cap)receivables ratio 1.2pts

The numbers the ratios are built from

Read from MCK's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.

LineFigureAs reportedRead from
RevenueTotal revenue for the period $403.4B 2026-03-31 RevenueFromContractWithCustomerExcludingAssessedTax
Interest-bearing debtShort and long-term borrowings $10.0B 2026-09-30 LongTermDebt, LongTermDebtAndCapitalLeaseObligationsCurrent
Cash and interest-bearing securitiesCash, equivalents and marketable securities $6.6B 2026-09-30 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
Total assetsBalance sheet total $92.3B 2026-09-30 Assets
Market capDenominator for AAOIFI $126.0B live quote price x shares
36-month average market capDenominator for S&P Shariah and MSCI M-Series $85.7B 756 trading days closes x shares
24-month average market capDenominator for Dow Jones Islamic Market $94.5B 504 trading days closes x shares
Non-permissible revenueInterest and excluded income $179.0M 2026-03-31 InvestmentIncomeInterest

Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.

Sources

Filing information. Balance sheet: Quarterly report (10-Q) filed 2026-11-04, period ended 2026-09-30. Income statement: Annual report (10-K) filed 2026-05-08, period ended 2026-03-31. Screened 2026-11-18.

  • Total assets$92.3B
    Assets · period ended 2026-09-30 · 10-Q filed 2026-11-04
  • Interest-bearing debt$10.0B
    LongTermDebt $9.2B · period ended 2026-09-30 · 10-Q filed 2026-11-04
    LongTermDebtAndCapitalLeaseObligationsCurrent $794.0M · period ended 2026-09-30 · 10-Q filed 2026-11-04
  • Cash and interest-bearing securities$6.6B
    CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · period ended 2026-09-30 · 10-Q filed 2026-11-04
  • Receivables$30.8B
    ReceivablesNetCurrent · period ended 2026-09-30 · 10-Q filed 2026-11-04
  • Revenue$403.4B
    RevenueFromContractWithCustomerExcludingAssessedTax · period ended 2026-03-31 · 10-K filed 2026-05-08
  • Interest income (non-permissible)$179.0M
    InvestmentIncomeInterest · period ended 2026-03-31 · 10-K filed 2026-05-08
  • Market cap$126.0B
    Market quote passed in by the screen (Finnhub company profile; Yahoo Finance where Finnhub has none), 2026-11-18 · not a filing figure, so no link

7 reported values cited from 2 SEC filings, read from SEC's XBRL company facts when this symbol was screened. A link opens the filing's index on EDGAR.

What changed, and when

Verdict history for MCK. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-11-18 Fail → Pass filing re-screen

Tracked since 2026-09-07.

Revenue by business segment

How MCK’s $403.4B of revenue for the fiscal year 2025-04-01 to 2026-03-31 splits across what it sells, as the company tags it in its own 10-K. The filing splits revenue by operating segment, not by product.

Fiscal year ended 2026-03-31
SegmentShareRevenue
North American Pharmaceutical 83.5% $336.7B
Oncology & Multispecialty 12.0% $48.4B
Medical-Surgical Solutions 2.9% $11.5B
Prescription Technology Solutions 1.4% $5.8B
Not broken out in the filing's tags 0.3% $1.0B

These are the company’s own segment names and figures. They do not say whether a line of business is permissible; our business-activity screen does.

Source: 10-K filed 2026-05-08 (accession 0000927653-26-000069), read from its XBRL on SEC EDGAR. Shares are of total revenue; subtotals and overlapping cuts the filing also tags are left out, so the lines add up to the total.

What would change the status

The headline verdict is the majority of the decided ratio standards — 6 pass and 1 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2026-09-30; market cap as stored on 2026-11-18.

Within 3 points of the line

Dow Jones Islamic is within 3 points of its line. Even if it crossed, the majority verdict would stay Compliant.

The ratios that move with the share price

AAOIFI's debt ratio (9.5% against a 30% line) would only fail if the market cap fell by 68%, to $39.9B.

AAOIFI's investments ratio (5.3% against a 30% line) would only fail if the market cap fell by 82%, to $22.1B.

Only AAOIFI divides by the market cap itself. The Dow Jones, S&P and MSCI M-Series standards divide by a 24- or 36-month average and the others by total assets, so a day's price move does not reach them. Figures are the screen's own; the live market cap differs from the stored one.

Shariah-compliant alternatives

Compliant companies in Medical Distribution listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.

CompanyMarket capPrice, day
AHGAkso Health Group $718.9M —
FOCLEDAP TMS S.A. American Depositary Shares $162.3M —

A dash means no fresh quote is cached for that symbol; this list does not fetch one.

Funds that hold MCK

33 of the 227 funds whose filed holdings we currently hold own MCK shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns MCK.

Shariah funds
FundMCK in fundFund compliant by weight
MNZL Manzil Russell Halal USA Broad Market ETF 0.39% 88%
SPUS SP Funds S&P 500 Sharia Industry Exclusions ETF 0.28% 79%
HLAL Wahed FTSE USA Shariah ETF 0.27% 72%
You may already own it

Widely held U.S. index funds. If you own one, you own MCK through it. None of them is a Shariah fund; the last column is our look-through of each.

FundMCK in fundFund compliant by weight
IWF iShares Russell 1000 Growth ETF 0.26% 69%
RSP Invesco S&P 500 Equal Weight ETF 0.21% 44%
SCHB Schwab U.S. Broad Market ETF 0.14% 53%
SPY 0.14% 56%
VOO VANGUARD 500 INDEX FUND 0.14% 56%
IVV iShares Core S&P 500 ETF 0.14% 56%
SPYM State Street(R) SPDR(R) Portfolio S&P 500(R) ETF 0.14% 56%
VTI VANGUARD TOTAL STOCK MARKET INDEX FUND 0.13% 54%
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.12% 54%
Other funds
FundMCK in fundFund compliant by weight
PEYAX Putnam Large Cap Value Fund 1.76% 42%
LMLSX ClearBridge Large Cap Value Fund 1.65% 49%
QUERX AQR Large Cap Defensive Style Fund 1.46% not computed
QSPIX AQR Style Premia Alternative Fund Also QSPNX 1.03% not computed
QRPNX AQR Alternative Risk Premia Fund Also QRPRX 0.89% not computed
SMYSX Franklin Global Equity Fund 0.74% 54%
JMOM JPMorgan U.S. Momentum Factor ETF 0.41% 54%
PFM Invesco Dividend AchieversTM ETF 0.37% 55%
LVPSX LARGE-CAP VALUE PROFUND 0.36% 50%
JPUS JPMorgan Diversified Return U.S. Equity ETF 0.34% 43%
11 more funds
FundMCK in fundFund compliant by weight
GONIX Gotham Neutral Fund 0.17% not computed
AAEQ Alpha Architect US Equity 2 ETF 0.16% 57%
SPYX State Street(R) SPDR(R) S&P(R) 500 Fossil Fuel Reserves Free ETF 0.15% 54%
RAFE PIMCO RAFI ESG U.S. ETF 0.15% 50%
PSIFX PGIM Quant Solutions Large-Cap Index Fund 0.14% 55%
FGCKX Fidelity Growth Company Fund 0.10% 56%
FLSPX Spectrum Fund 0.10% not computed
VT VANGUARD TOTAL WORLD STOCK INDEX FUND 0.09% 50%
ILCG iShares Morningstar Growth ETF 0.09% 68%
IIFSX Voya Balanced Income Portfolio 0.08% not computed
GVLU Gotham 1000 Value ETF 0.08% 39%

Sorted by MCK’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names MCK once, so a bond is not counted as the shares; 4 more funds name MCK in a way we cannot separate from its bonds, and are not listed. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.

Tracked investors holding MCK
InvestorFirmPositionWeightAs of
Stephen Mandel Lone Pine Capital $649M 4.2% 2026-09-30
David Shaw D. E. Shaw & Co. $449M 0.2% 2026-09-30
Ken Griffin Citadel Advisors $342M 0.0% 2026-09-30
Peter Brown Renaissance Technologies $167M 0.2% 2026-09-30
Frank Sands Sands Capital Management $149M 0.6% 2026-09-30
Israel Englander Millennium Management $139M 0.0% 2026-09-30
Charles Brandes Brandes Investment Partners $119M 0.8% 2026-09-30
Ray Dalio Bridgewater Associates $62M 0.3% 2026-09-30
Joel Greenblatt Gotham Asset Management $55M 0.1% 2026-09-30
Steven Cohen Point72 Asset Management $40M 0.0% 2026-09-30
Paul Tudor Jones Tudor Investment Corp $25M 0.0% 2026-09-30
Ron Muhlenkamp Muhlenkamp & Co $23M 5.7% 2026-09-30
Azzad Asset Management Azzad Asset Management $4M 0.3% 2026-09-30
Ken Fisher Fisher Asset Management $3M 0.0% 2026-09-30
Lee Ainslie Maverick Capital $3M 0.0% 2026-09-30
Wahed Invest Wahed Invest LLC $2M 0.2% 2026-06-30
Sallie Krawcheck Ellevest $1M 0.1% 2026-09-30

From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.

1,105.041,009.68914.32818.96723.602025-11-182026-05-212026-11-18

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
1057.24
S2
1071.20
S1
1081.44
PIVOT
1095.40
R1
1105.64
R2
1119.60
R3
1129.84

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
802.31 – 910.27
±6.3% from 856.29, made 2026-09-28 · resolves 2026-10-05
SELL
from 19 indicators
77.1% of our last 20463 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 50.1% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG BUY
19 indicators
OscillatorsSTRONG BUY
3 buy · 4 neutral · 0 sell
Moving averagesSTRONG BUY
12 buy · 0 neutral · 0 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)64.80NEUTRAL
Stochastic %K (14)69.28NEUTRAL
CCI (20)63.56NEUTRAL
Williams %R (14)-30.72NEUTRAL
MACD (12,26,9)1.19BUY
ROC (10)0.91BUY
Momentum (10)9.71BUY
EMA (10)1074.70BUY
SMA (10)1081.03BUY
EMA (20)1047.06BUY
SMA (20)1039.34BUY
EMA (30)1023.35BUY
SMA (30)1020.32BUY
EMA (50)987.07BUY
SMA (50)966.83BUY
EMA (100)933.95BUY
SMA (100)909.34BUY
EMA (200)895.48BUY
SMA (200)876.90BUY

About MCK

Healthcare · Medical Distribution

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, hospital reference labs, nursing homes, hospice and home health care agencies, government facilities, and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

mckesson.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Latest Signal — 2026-09-21

MOM
Type · SCALP
892.72
Entry
883.79
Stop
910.58
Target
LOSS
Outcome · exit 883.79 (-1.00%)

Stop 883.79 Now 1081.88 Target 910.58

Verdict

🟢 STRONG BUY SETUP

Strong confluence across multiple layers — outperforming the market by 11.3%, RSI in healthy zone, Wall Street broadly bullish. High conviction entry. Use `!plan MCK [entry] [stop] [target]` to size the position properly.

Scores: 4 bullish / 1 bearish

Grade verdict

No real edge — avoid

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily RANGING 64
⏰ 4H BULLISH 37
🕐 1H BEARISH 98
⏱ 15-Min BEARISH 130
⏲ 5-Min BULLISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

+0.7%
Rate of change (10d)
2.5×
Volume vs its 20-day average
36.19
MACD (no fresh cross)
$1080.79
Volume POC (today)
$1079.23 – $1083.59
Value area

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

BEARISH   0 buys · 2 sells

Recent: TYLER BRIAN S. sold 14382 sh @ $775.13 (2026-06-17); TYLER BRIAN S. sold 5919 sh @ $793.56 (2026-07-07)

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-10 · Asset managers net 914130 (-14454)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.